Sectors
PRLD
Prelude Therapeutics Incorporated
4.00
3 x 4.00
3 x 4.02
bid
ask
-
0.04
0.89%
10:01 AM
timesize
| Ytd | 38.07% | |
| 1y | 368.52% |
4.00
day range
4.07
0.75
52 week range
5.69
| Open | 4.02 | Prev Close | 4.04 | Low | 4.00 | High | 4.07 | Mkt Cap | 230.01M |
| Vol | 8.31K | Avg Vol | 459.27K | EPS | -1.00 | P/E | -4.04 | Forward P/E | -0.82 |
| Beta | 0.95 | Short Ratio | 7.51 | Inst. Own | 84.98% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 4.37 | 200-d Avg | 3.00 | 1yr Est | 5.00 |
| Income Statement | |||
| Total Revenue | 4.58M | ||
| Revenues (USD) | 4.58M | ||
| Gross Profit | 4.58M | ||
| Operating Expenses | 18.76M | ||
| Research and Development Expense | 13.60M | ||
| Selling, General and Administrative Expense | 5.16M | ||
| Operating Income | -14.18M | ||
| Net Income | -10.38M | ||
| Net Income Common Stock | -10.38M | ||
| Net Income Common Stock (USD) | -10.38M | ||
| Consolidated Income | -10.38M | ||
| Earnings per Basic Share | -0.13 | ||
| Earnings per Basic Share (USD) | -0.13 | ||
| Earnings per Diluted Share | -0.13 | ||
| Earning Before Interest & Taxes (EBIT) | -10.38M | ||
| Earning Before Interest & Taxes (USD) | -10.38M | ||
| Weighted Average Shares | 82.52M | ||
| Weighted Average Shares Diluted | 82.52M | ||
| Balance Sheet | |||
| Cash and Equivalents | 24.99M | ||
| Cash and Equivalents (USD) | 24.99M | ||
| Investments | 59.80M | ||
| Investments Current | 59.80M | ||
| Current Assets | 84.59M | ||
| Property, Plant & Equipment Net | 31.50M | ||
| Total Assets | 119.64M | ||
| Debt Current | 2.76M | ||
| Total Debt | 17.72M | ||
| Current Liabilities | 41.72M | ||
| Debt Non-Current | 14.96M | ||
| Total Liabilities | 59.46M | ||
| Accumulated Retained Earnings (Deficit) | -693.45M | ||
| Accumulated Other Comprehensive Income | -41.00K | ||
| Shareholders Equity | 60.18M | ||
| Shareholders Equity (USD) | 60.18M | ||
| Assets Non-Current | 35.05M | ||
| Total Debt (USD) | 17.72M | ||
| Deferred Revenue | 30.95M | ||
| Liabilities Non-Current | 17.74M | ||
| Trade and Non-Trade Payables | 2.07M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 778.00K | ||
| Net Cash Flow from Financing | -314.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -13.50M | ||
| Issuance (Purchase) of Equity Shares | 31.00K | ||
| Net Cash Flow from Investing | 8.50M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 8.50M | ||
| Net Cash Flow from Operations | -21.68M | ||
| Share Based Compensation | 2.00M | ||